Modus Therapeutics resolves directed share issue at SEK 0.38
Modus Therapeutics’ board resolved a directed new issue of 20,000,000 shares at a subscription price of SEK 0.38, pursuant to AGM authorisation from 28 May 2026.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.